1. Home
  2. HTCR vs ADXN Comparison

HTCR vs ADXN Comparison

Compare HTCR & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$0.32

Market Cap

11.7M

Sector

Technology

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$8.33

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
ADXN
Founded
2009
2002
Country
Japan
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
10.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HTCR
ADXN
Price
$0.32
$8.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
186.4K
8.1K
Earning Date
11-18-2025
12-04-2025
Dividend Yield
41.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,189,136.00
$198,824.00
Revenue This Year
N/A
$86.57
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$6.51
52 Week High
$1.76
$12.05

Technical Indicators

Market Signals
Indicator
HTCR
ADXN
Relative Strength Index (RSI) 35.80 52.53
Support Level $0.31 $7.00
Resistance Level $0.35 $10.43
Average True Range (ATR) 0.03 0.53
MACD 0.01 0.06
Stochastic Oscillator 23.33 38.78

Price Performance

Historical Comparison
HTCR
ADXN

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: